+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Vectura Group plc - logo

Vectura Pharma was established in 1997, and its headquarters are in Chippenham in the U.K. Vectura Group plc researches, develops, and commercializes novel therapeutic products and drug delivery systems for the treatment of airways-related diseases Vectura entered into its first global commercialisation and development agreement with Novartis for NVA237. The company’s marketed products include Ultibro Breezhaler and Seebri Breezhaler for the treatment of chronic obstructive pulmonary disease (COPD).

Nasal Polyps Treatment Global Market Report 2024 - Product Thumbnail Image

Nasal Polyps Treatment Global Market Report 2024

  • Report
  • December 2023
  • 200 Pages
  • Global
From
Biologics Global Market Report 2024 - Product Thumbnail Image

Biologics Global Market Report 2024

  • Report
  • February 2024
  • 400 Pages
  • Global
From
Pharmaceutical Drugs Global Market Report 2024 - Product Thumbnail Image

Pharmaceutical Drugs Global Market Report 2024

  • Report
  • February 2024
  • 400 Pages
  • Global
From
Idiopathic Pulmonary Fibrosis Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type - Product Thumbnail Image

Idiopathic Pulmonary Fibrosis Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type

  • Report
  • February 2024
  • 88 Pages
  • Global
From
Asthma - Pipeline Review, H2 2020 - Product Thumbnail Image

Asthma - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 811 Pages
  • Global
From
COPD Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

COPD Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • May 2023
  • 109 Pages
  • Global
From
Anti-Viral Drug Therapy Global Market Opportunities and Strategies to 2030: COVID-19 Implications and Growth - Product Thumbnail Image

Anti-Viral Drug Therapy Global Market Opportunities and Strategies to 2030: COVID-19 Implications and Growth

  • Report
  • December 2020
  • Global
From
Cystic Fibrosis - Pipeline Review, H2 2020 - Product Thumbnail Image

Cystic Fibrosis - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 550 Pages
  • Global
From
Global Mergers and Acquisitions (M&A) Deals in 2021 - Top Themes in the Pharmaceuticals Sector - Thematic Research - Product Thumbnail Image

Global Mergers and Acquisitions (M&A) Deals in 2021 - Top Themes in the Pharmaceuticals Sector - Thematic Research

  • Report
  • January 2022
  • 28 Pages
  • Global
From
PharmSource - CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance - 2019 Edition - Product Thumbnail Image

PharmSource - CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance - 2019 Edition

  • Report
  • March 2019
  • 50 Pages
  • Global
From
Vectura Group plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis - Product Thumbnail Image

Vectura Group plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

  • Company Profile
  • May 2024
  • 50 Pages
From
Vectura Group Plc - Product Pipeline Analysis, 2022 Update - Product Thumbnail Image

Vectura Group Plc - Product Pipeline Analysis, 2022 Update

  • Company Profile
  • July 2022
  • 37 Pages
From
Vectura Group Plc - Strategic SWOT Analysis Review - Product Thumbnail Image

Vectura Group Plc - Strategic SWOT Analysis Review

  • SWOT Analysis
  • November 2023
  • 26 Pages
From
Vectura Group plc - Strategy, SWOT and Corporate Finance Report - Product Thumbnail Image

Vectura Group plc - Strategy, SWOT and Corporate Finance Report

  • SWOT Analysis
  • November 2023
  • 35 Pages
From
Loading Indicator